Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Biphasic isophane insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Humulin insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Initard insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Pur-In-Mix insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Mixtard insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Biphasic insulin allergy |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Insuline humaine recombinante isophane biphasique |
Is a |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Biphasic insulin adverse reaction |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
1 |
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Product containing insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biphasic insulin |
Inferred relationship |
Some |
|
Biphasic insulin allergy |
Causative agent (attribute) |
False |
Biphasic insulin |
Inferred relationship |
Some |
1 |
Product containing biphasic insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Biphasic insulin |
Inferred relationship |
Some |
1 |